Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Cell Transplantation and Cell Therapy Group (GETH-TC)"'
Autor:
José Luis Piñana, Lourdes Vazquez, Marisa Calabuig, Lucia López-Corral, Gabriel Martin-Martin, Lucia Villalon, Gabriela Sanz-Linares, Venancio Conesa-Garcia, Andrés Sanchez-Salinas, Beatriz Gago, Ana Facal, Irene Risco-Gálvez, María T. Olave, Ildefonso Espigado, Javier Lopez-Jimenez, José Ángel Hernández-Rivas, Alejandro Avendaño-Pita, Ignacio Arroyo, Elena Ferrer, Irene García-Cadenas, Clara González-Santillana, Alicia Roldán-Pérez, Blanca Ferrer, Manuel Guerreiro, María Suarez-Lledó, Angela Camara, Diana Campos-Beltrán, David Navarro, Ángel Cedillo, Anna Sureda, Carlos Solano, Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC), Rodrigo Martino
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract The long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has been little explored. A prospective multicenter registry-based cohort study conducted from
Externí odkaz:
https://doaj.org/article/da41ce1978d245428ba9b7f45cad2ea8
Autor:
José Luis Piñana, Lucia López-Corral, Rodrigo Martino, Lourdes Vazquez, Ariadna Pérez, Gabriel Martin-Martin, Beatriz Gago, Gabriela Sanz-Linares, Andrés Sanchez-Salinas, Lucia Villalon, Venancio Conesa-Garcia, María T. Olave, Magdalena Corona, Sara Marcos-Corrales, Mar Tormo, José Ángel Hernández-Rivas, Juan Montoro, Alicia Rodriguez-Fernandez, Irene Risco-Gálvez, Pablo Rodríguez-Belenguer, Juan Carlos Hernandez-Boluda, Irene García-Cadenas, Montserrat Ruiz-García, Juan Luis Muñoz-Bellido, Carlos Solano, Ángel Cedillo, Anna Sureda, David Navarro, the Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-11 (2022)
Abstract Background The clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has not yet been established. Patients and methods A prospective multicenter registry-based co
Externí odkaz:
https://doaj.org/article/da55a96642cf49a1b9e2839f401c805d
Autor:
Piñana, José Luis, Rodríguez-Belenguer, Pablo, Caballero, Dolores, Martino, Rodrigo, Lopez-Corral, Lucia, Terol, María-José, Vazquez, Lourdes, Calabuig, Marisa, Sanz-Linares, Gabriela, Marin-Jimenez, Francisca, Alonso, Carmen, Montoro, Juan, Ferrer, Elena, Facal, Ana, Pascual, María-Jesús, Rodriguez-Fernandez, Alicia, Olave, María T, Cascales-Hernandez, Almudena, Gago, Beatriz, Hernández-Rivas, José-Ángel, Villalon, Lucia, Corona, Magdalena, Roldán-Pérez, Alicia, Ribes-Amoros, Julia, González-Santillana, Clara, Garcia-Sanz, Ramon, Navarro, David, Serrano-López, Antonio J, Cedillo, Ángel, Soria-Olivas, Emilio, Sureda, Anna, Solano, Carlos, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)
Publikováno v:
ANNALS OF HEMATOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Digital.CSIC. Repositorio Institucional del CSIC
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Digital.CSIC. Repositorio Institucional del CSIC
Prior studies of antibody response after full SARS-CoV-2 vaccination in hematological patients have confirmed lower antibody levels compared to the general population. Serological response in hematological patients varies widely according to the dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ee58c62e7825d035489b66d008a3ba
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16814
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16814
Autor:
Pinana J, Lopez-Corral L, Martino R, Montoro J, Vazquez L, Perez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual M, Sanz-Linares G, Gago B, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave M, Lopez-Jimenez J, Marcos-Corrales S, Garcia-Blazquez M, Garcia-Gutierrez V, Hernandez-Rivas J, Saus A, Espigado I, Alonso C, Hernani R, Solano C, Ferrer-Lores B, Guerreiro M, Ruiz-Garcia M, Munoz-Bellido J, Navarro D, Cedillo A, Sureda A, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem, Cell Transplantation and Cell Therapy Group (GETH-TC)
Publikováno v:
AMERICAN JOURNAL OF HEMATOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
This is a multicenter prospective observational study that included a large cohort (n=397) of allogeneic (allo-HSCT; (n=311) and autologous (ASCT) hematopoietic stem cell transplant (n=86) recipients who were monitored for antibody detection within 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::eb5b52c11b6f100e6540b77c74f7f743
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16091
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16091
Autor:
Piñana, José Luis, López-Corral, Lucia, Martino, Rodrigo, Montoro, Juan, Vazquez, Lourdes, Pérez, Ariadna, Martin-Martin, Gabriel, Facal-Malvar, Ana, Ferrer, Elena, Pascual, María-Jesús, Sanz-Linares, Gabriela, Gago, Beatriz, Sanchez-Salinas, Andrés, Villalon, Lucia, Conesa-Garcia, Venancio, Olave, Maria T, López-Jimenez, Javier, Marcos-Corrales, Sara, García-Blázquez, Marta, Garcia-Gutiérrez, Valentín, Hernández-Rivas, José Ángel, Saus, Ana, Espigado, Ildefonso, Alonso, Carmen, Hernani, Rafael, Solano, Carlos, Ferrer-Lores, Blanca, Guerreiro, Manuel, Ruiz-García, Montserrat, Muñoz-Bellido, Juan Luis, Navarro, David, Cedillo, Angel, Sureda, Anna, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)
This is a multicenter prospective observational study that included a large cohort (n = 397) of allogeneic (allo-HSCT; (n = 311) and autologous (ASCT) hematopoietic stem cell transplant (n = 86) recipients who were monitored for antibody detection wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2636::177822d07ebdf324ad37b5d786ddcb84
https://hdl.handle.net/10668/19952
https://hdl.handle.net/10668/19952
Autor:
Piñana JL; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain., Vazquez L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Heras I; Hematology Division, Hospital Morales Meseguer, Murcia, Spain., Aiello TF; Infectious Disease Division, Hospital Clinic, Barcelona, Spain., López-Corral L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Arroyo I; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain., Soler-Espejo E; Hematology Division, Hospital Morales Meseguer, Murcia, Spain., García-Cadenas I; Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Garcia-Gutierrez V; Hematology Division, Hospital Ramon y Cajal, Madrid, Spain., Aroca C; Hematology Division, Hospital Morales Meseguer, Murcia, Spain., Chorao P; Hematology Division, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Olave MT; Hematology Division, Hospital Clínico Universitario Lozano Blesa, IIS Aragon, Zaragoza, Spain., Lopez-Jimenez J; Hematology Division, Hospital Ramon y Cajal, Madrid, Spain., Gómez MA; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Arellano E; Hematology Division, Hospital Universitario Virgen Macarena, Sevilla, Spain., Cuesta-Casas M; Hematology Division, Hospital Regional Universitario Carlos Haya, Malaga, Spain., Avendaño-Pita A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., González-Santillana C; Hematology Division, Hospital de Fuenlabrada, Madrid, Spain., Hernández-Rivas JÁ; Hematology Division, Hospital Universitario Infanta Leonor, Madrid, Spain., Roldán-Pérez A; Hematology Division, Hospital Infanta Sofia, Madrid, Spain., Mico-Cerdá M; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain., Guerreiro M; Hematology Division, Hospital Clínico Universitario Lozano Blesa, IIS Aragon, Zaragoza, Spain., Morell J; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain., Rodriguez-Galvez P; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain., Labrador J; Research unit, Hospital Universitario de Burgos, Burgos, Spain., Campos D; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain.; Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany., Cedillo Á; Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) office, Madrid, Spain., Vidal CG; Hematology Division, Hospital Morales Meseguer, Murcia, Spain., Martino R; Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Solano C; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; INCLIVA Biomedical Research Institute, Valencia, Spain.; Department of Medicine, School of Medicine. University of Valencia, Valencia, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Jun 19; Vol. 14, pp. 1389345. Date of Electronic Publication: 2024 Jun 19 (Print Publication: 2024).
Autor:
Piñana JL; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain., Heras I; Hematology Division, Hospital Morales Meseguer, 30100 Murcia, Spain., Aiello TF; Infectious Disease Division, Hospital Clinic, 08193 Barcelona, Spain., García-Cadenas I; Hematology Division, Hospital de la Santa Creu i Sant Pau, 08193 Barcelona, Spain., Vazquez L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Lopez-Jimenez J; Hematology Division, Hospital Ramon y Cajal, 28029 Madrid, Spain., Chorão P; Hematology Division, Hospital Universitario y Politécnico La Fe, 46017 Valencia, Spain., Aroca C; Hematology Division, Hospital Morales Meseguer, 30100 Murcia, Spain., García-Vidal C; Infectious Disease Division, Hospital Clinic, 08193 Barcelona, Spain., Arroyo I; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain., Soler-Espejo E; Hematology Division, Hospital Morales Meseguer, 30100 Murcia, Spain., López-Corral L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Avendaño-Pita A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., Arrufat A; Hematology Division, Hospital de la Santa Creu i Sant Pau, 08193 Barcelona, Spain., Garcia-Gutierrez V; Hematology Division, Hospital Ramon y Cajal, 28029 Madrid, Spain., Arellano E; Hematology Division, Hospital Universitario Virgen Macarena, 41092 Sevilla, Spain., Hernández-Medina L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain., González-Santillana C; Hematology Division, Hospital de Fuenlabrada, 28029 Madrid, Spain., Morell J; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain., Hernández-Rivas JÁ; Hematology Division, Hospital Universitario Infanta Leonor, 28029 Madrid, Spain., Rodriguez-Galvez P; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain., Mico-Cerdá M; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain., Guerreiro M; Hematology Division, Hospital Universitario y Politécnico La Fe, 46017 Valencia, Spain., Campos D; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain.; Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Brain, Behavior and Metabolism (CBBM), University of Lübeck, 23562 Lübeck, Germany., Navarro D; Microbiology Service, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.; Department of Medicine, School of Medicine. University of Valencia, 46010 Valencia, Spain., Cedillo Á; Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) Office, 28029 Madrid, Spain., Martino R; Hematology Division, Hospital de la Santa Creu i Sant Pau, 08193 Barcelona, Spain., Solano C; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain.; Department of Medicine, School of Medicine. University of Valencia, 46010 Valencia, Spain.
Publikováno v:
Viruses [Viruses] 2023 Oct 08; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 08.
Autor:
Piñana JL; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain. jlpinana@gmail.com.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain. jlpinana@gmail.com., Vazquez L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain., Calabuig M; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain., López-Corral L; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain., Martin-Martin G; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain., Villalon L; Hematology Division, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Sanz-Linares G; Hematology Division, Institut Català Oncologia-Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Conesa-Garcia V; Hematology Division, Hospital General universitario de Elche, Elche, Spain., Sanchez-Salinas A; Hematology Division, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Gago B; Hematology Division, Hospital Regional Universitario Carlos Haya, Malaga, Spain., Facal A; Hematology Division, Hospital universitario y politécnico La Fe, Valencia, Spain., Risco-Gálvez I; Hematology Division, Hospital Arnau de Vilanova, Valencia, Spain., Olave MT; Hematology Division, Hospital Clínico Universitario Lozano Blesa, IIS Aragon, Zaragoza, Spain., Espigado I; Hematology Division, Hospital Universitario Virgen Macarena, Sevilla, Spain., Lopez-Jimenez J; Hematology Division, Hospital Ramon y Cajal, Madrid, Spain., Hernández-Rivas JÁ; Hematology Division, Hospital Universitario Infanta Leonor, Madrid, Spain., Avendaño-Pita A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain., Arroyo I; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain., Ferrer E; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain., García-Cadenas I; Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., González-Santillana C; Hematology Division, Hospital de Fuenlabrada, Madrid, Spain., Roldán-Pérez A; Hematology división, Hospital Infanta Sofia, Madrid, Spain., Ferrer B; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain., Guerreiro M; Hematology Division, Hospital universitario y politécnico La Fe, Valencia, Spain., Suarez-Lledó M; Hematology Division, Hospital Clinic de Barcelona, Barcelona, Spain., Camara A; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain., Campos-Beltrán D; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.; Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany., Navarro D; Microbiology department, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain., Cedillo Á; Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) office, Madrid, Spain., Sureda A; Hematology Division, Institut Català Oncologia-Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Solano C; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain., Martino R; Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Jan 05; Vol. 13 (1), pp. 8. Date of Electronic Publication: 2023 Jan 05.